Rising costs, unpredictable policies, and dwindling incentives are forcing Big Pharma to rethink the UK, with leading firms pausing multi-million-pound R&D projects, but why is the country losing its competitive edge?
The NHS will provide a new triple combination therapy to hundreds of children and adults with cystic fibrosis in England, aiming to improve lung function and quality of life for eligible patients.
UC Berkeley scientists unveil a powerful new at-home test using nanotech and AI to detect diseases like COVID-19 and cancer with unprecedented sensitivity.
The MHRA has executed a significant operation, seizing a staggering 7.7 million doses of illegal medicines and eliminating hundreds of illicit online listings.
Cardiff University spin-out Draig Therapeutics has been awarded £107m ($140m) to advance the development of novel therapies for major neuropsychiatric disorders.
A revolutionary STI test developed by UK-based Linear Diagnostics, a University of Birmingham spin-out company, delivers lab-accurate results in five minutes.
An 'AI scientist', working in collaboration with human scientists, has discovered that combinations of cheap and safe drugs could be effective at treating breast cancer.
In a groundbreaking first, psilocybin is entering gastroenterology. Dr. Erin Mauney leads a pioneering study exploring how psychedelic therapy could transform treatment for millions suffering from treatment-resistant Irritable Bowel Syndrome, offering new hope for gut-brain disorders.
Jacqueline Alvarez, Chief of the Chemicals and Health Branch at the UN Environment Programme (UNEP), explores the importance of holistic, One Health efforts to mitigate the growing threat of antimicrobial resistance.
